Impact of Intrahepatic Tumor Burden on Outcomes in Patients With Hepatocellular Carcinoma With Extrahepatic Metastases Treated With Atezolizumab Plus Bevacizumab.

Tanaka K, Tsuji K, Hiraoka A, Tada T, Hirooka M, Kariyama K, Tani J, Atsukawa M, Takaguchi K, Itobayashi E, Fukunishi S, Ishikawa T, Tajiri K, Tanaka H, Toyoda H, Ogawa C, Nishimura T, Hatanaka T, Kakizaki S, Kawata K, Naganuma A, Kosaka H, Matono T, Ueda Y, Kuroda H, Yata Y, Nishikawa H, Imai M, Aoki T, Ochi H, Okamura J, Tamai H, Nakamura S, Nakamura Y, Yoshida O, Nouso K, Morishita A, Itokawa N, Okubo T, Arai T, Tsutsui A, Nagano T, Tada F, Ohama H, Koshiyama Y, Kanayama Y, Noritake H, Komatsu S, Fukumoto T, Matsuura T, Kim SK, Enomoto H, Matsui K, Kaibori M, Hiasa Y, Kudo M, Kumada T, Real‐Life Practice Experts for HCC (RELPEC) Study Group and Hepatocellular Carcinoma Experts From 48 Clinics in Japan (HCC 48) Group

Open source

DOI: 10.1111/hepr.70178
Published: 2026 Aug
Container: Hepatology research : the official journal of the Japan Society of Hepatology
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1111/hepr.70178,
  title = {Impact of Intrahepatic Tumor Burden on Outcomes in Patients With Hepatocellular Carcinoma With Extrahepatic Metastases Treated With Atezolizumab Plus Bevacizumab.},
  author = {Tanaka K and Tsuji K and Hiraoka A and Tada T and Hirooka M and Kariyama K and Tani J and Atsukawa M and Takaguchi K and Itobayashi E and Fukunishi S and Ishikawa T and Tajiri K and Tanaka H and Toyoda H and Ogawa C and Nishimura T and Hatanaka T and Kakizaki S and Kawata K and Naganuma A and Kosaka H and Matono T and Ueda Y and Kuroda H and Yata Y and Nishikawa H and Imai M and Aoki T and Ochi H and Okamura J and Tamai H and Nakamura S and Nakamura Y and Yoshida O and Nouso K and Morishita A and Itokawa N and Okubo T and Arai T and Tsutsui A and Nagano T and Tada F and Ohama H and Koshiyama Y and Kanayama Y and Noritake H and Komatsu S and Fukumoto T and Matsuura T and Kim SK and Enomoto H and Matsui K and Kaibori M and Hiasa Y and Kudo M and Kumada T and Real‐Life Practice Experts for HCC (RELPEC) Study Group and Hepatocellular Carcinoma Experts From 48 Clinics in Japan (HCC 48) Group},
  year = {2026},
  journal = {Hepatology research : the official journal of the Japan Society of Hepatology},
  doi = {10.1111/hepr.70178},
  url = {https://doi.org/10.1111/hepr.70178}
}

RIS

TY  - JOUR
TI  - Impact of Intrahepatic Tumor Burden on Outcomes in Patients With Hepatocellular Carcinoma With Extrahepatic Metastases Treated With Atezolizumab Plus Bevacizumab.
AU  - Tanaka K
AU  - Tsuji K
AU  - Hiraoka A
AU  - Tada T
AU  - Hirooka M
AU  - Kariyama K
AU  - Tani J
AU  - Atsukawa M
AU  - Takaguchi K
AU  - Itobayashi E
AU  - Fukunishi S
AU  - Ishikawa T
AU  - Tajiri K
AU  - Tanaka H
AU  - Toyoda H
AU  - Ogawa C
AU  - Nishimura T
AU  - Hatanaka T
AU  - Kakizaki S
AU  - Kawata K
AU  - Naganuma A
AU  - Kosaka H
AU  - Matono T
AU  - Ueda Y
AU  - Kuroda H
AU  - Yata Y
AU  - Nishikawa H
AU  - Imai M
AU  - Aoki T
AU  - Ochi H
AU  - Okamura J
AU  - Tamai H
AU  - Nakamura S
AU  - Nakamura Y
AU  - Yoshida O
AU  - Nouso K
AU  - Morishita A
AU  - Itokawa N
AU  - Okubo T
AU  - Arai T
AU  - Tsutsui A
AU  - Nagano T
AU  - Tada F
AU  - Ohama H
AU  - Koshiyama Y
AU  - Kanayama Y
AU  - Noritake H
AU  - Komatsu S
AU  - Fukumoto T
AU  - Matsuura T
AU  - Kim SK
AU  - Enomoto H
AU  - Matsui K
AU  - Kaibori M
AU  - Hiasa Y
AU  - Kudo M
AU  - Kumada T
AU  - Real‐Life Practice Experts for HCC (RELPEC) Study Group and Hepatocellular Carcinoma Experts From 48 Clinics in Japan (HCC 48) Group
PY  - 2026
JO  - Hepatology research : the official journal of the Japan Society of Hepatology
DO  - 10.1111/hepr.70178
UR  - https://doi.org/10.1111/hepr.70178
ER  -

APA

K, T., K, T., A, H., T, T., M, H., K, K., J, T., M, A., K, T., E, I., S, F., T, I., K, T., H, T., H, T., C, O., T, N., T, H., S, K., K, K., A, N., H, K., T, M., Y, U., H, K., Y, Y., H, N., M, I., T, A., H, O., J, O., H, T., S, N., Y, N., O, Y., K, N., A, M., N, I., T, O., T, A., A, T., T, N., F, T., H, O., Y, K., Y, K., H, N., S, K., T, F., T, M., SK, K., H, E., K, M., M, K., Y, H., M, K., T, K., & Group, R. P. E. F. H. (. S. G. A. H. C. E. F. 4. C. I. J. (. 4. (2026). Impact of Intrahepatic Tumor Burden on Outcomes in Patients With Hepatocellular Carcinoma With Extrahepatic Metastases Treated With Atezolizumab Plus Bevacizumab.. Hepatology research : the official journal of the Japan Society of Hepatology. https://doi.org/10.1111/hepr.70178

Source records

pubmed · retrieved 2026-09-26T14:44:46.467Z